Virtu Financial LLC - HISTOGENICS CORP ownership

HISTOGENICS CORP's ticker is HSGX and the CUSIP is 43358V109. A total of 30 filers reported holding HISTOGENICS CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of HISTOGENICS CORP
ValueSharesWeighting
Q2 2019$83,000
+20.3%
435,497
-26.6%
0.01%
+25.0%
Q1 2019$69,000
+666.7%
592,976
+505.8%
0.00%
Q4 2018$9,000
-92.3%
97,880
-54.1%
0.00%
-100.0%
Q3 2018$117,000
+108.9%
213,352
+950.2%
0.01%
+133.3%
Q1 2018$56,000
-56.9%
20,316
-68.0%
0.00%
-57.1%
Q4 2017$130,000
+420.0%
63,563
+413.4%
0.01%
+600.0%
Q3 2017$25,00012,3810.00%
Other shareholders
HISTOGENICS CORP shareholders Q2 2018
NameSharesValueWeighting ↓
S Squared Technology, LLC 1,169,387$2,923,0002.32%
Abingworth LLP 888,889$2,204,0001.26%
Sofinnova Investments, Inc. 4,154,080$10,386,0000.66%
Third Security, LLC 2,690,570$6,726,0000.54%
Archon Capital Management LLC 293,090$733,0000.23%
Perceptive Advisors 2,203,277$5,508,0000.14%
Endurant Capital Management LP 56,177$140,0000.06%
Sio Capital Management, LLC 39,175$98,0000.05%
Palo Alto Investors LP 302,922$757,0000.03%
Rossmore Private Capital 11,236$28,0000.02%
View complete list of HISTOGENICS CORP shareholders